Elsevier

Experimental Cell Research

Volume 315, Issue 16, 1 October 2009, Pages 2791-2801
Experimental Cell Research

Research Article
Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos

https://doi.org/10.1016/j.yexcr.2009.06.023Get rights and content

Abstract

Presenilin1 (PSEN1) and presenilin2 (PSEN2) are involved in the processing of type-1 transmembrane proteins including the amyloid precursor protein (APP), Notch and several others. PSEN1 has been shown to be crucial for proteolytic cleavage of Notch in developing animal embryos. Mouse embryos lacking Psen1 function show disturbed neurogenesis and somite formation, resembling Notch pathway mutants. However, loss of Psen2 activity reveals only a minor phenotype. Zebrafish embryos are a valuable tool for analysis of the molecular genetic control of cell differentiation since endogenous gene expression can be modulated in subtle and complex ways to give a phenotypic readout. Using injection of morpholino antisense oligonucleotides to inhibit protein translation in zebrafish embryos, we show that reduced Psen2 activity decreases the number of melanocytes in the trunk but not in the cranial area at 2 days post fertilisation (dpf). Reduced Psen2 activity apparently reduces Notch signalling resulting in perturbed spinal neurogenin1 (neurog1) expression, neurogenesis and trunk and tail neural crest development. Similar effects are seen for reduced Psen1 activity. These results suggest that Psen2 plays a more prominent role in Notch signalling and embryo development in zebrafish than in mammals. Intriguingly, decreased Psen2 activity increases the number of Dorsal Longitudinal Ascending (DoLA) interneurons in the spinal cord while decreased Psen1 activity has no effect. However, the effect on DoLAs of reduced Psen2 can be ameliorated by Psen1 loss. The effects of changes in Psen2 activity on DoLA interneurons and other cells in zebrafish embryos provide bioassays for more detailed dissection of Psen2 function.

Introduction

The presenilin genes, PSEN1 and PSEN2 were discovered as loci mutated in a large proportion of human pedigrees showing inherited early onset Alzheimer's disease. These two genes with closely related structures encode components of “γ-secretase” complexes that cleave transmembrane proteins within lipid bilayers including the Notch receptor, amyloid precursor protein, E-cadherin, Nectin1 and others [1], [2]. Presenilins are also known to act in phosphorylation of β-catenin [3], as calcium channels that allow calcium ions to flow from the ER into the cytoplasm [4] and in processing and trafficking of tyrosinase required for conversion of tyrosine into the pigment melanin [5]. In addition, presenilin1 and presenilin2 may have other undiscovered functions since they have been observed in interphase kinetochores in the nucleus [6].

All non-human vertebrates studied to date appear to have single orthologues of the two presenilin genes. Knockout of mouse Psen1 showed that this gene has essential functions during embryo development [7]. The phenotype of mice lacking Psen1 activity is very similar to that of loss of Notch1 function implying that one of the major activities controlled by Psen1 during development is Notch signalling. In contrast, mice lacking Psen2 activity are viable and fertile and show only subtle changes in lung tissue and lung haemorrhage [8], [9]. Psen2 has previously been identified as regulating apoptosis and a truncated form of Psen2 protein was shown to inhibit apoptosis in a cultured cell survival assay [10]. However, progress in understanding the function of Psen2 has been hampered by lack of an assay for its non-apoptotic activities.

Presenilin proteins exist in a variety of isoforms. The longest forms of these proteins appear to have nine transmembrane domains although the conformation has been disputed [11], [12]. The form of presenilin protein that is active in the γ-secretase complex (together with cofactors nicastrin, PEN2 and APH1) is cleaved endoproteolytically within the “cytoplasmic loop” domain to form N- and C-terminal fragments (NTF and CTF). In previous work we have identified the zebrafish orthologue of human PSEN2 [13] and we have examined protein expression and function of the zebrafish orthologue of human PSEN1 in embryogenesis [14], [15]. By injection of antisense morpholino oligonucleotides (“morpholinos”) which bind to zebrafish psen1 mRNA to inhibit translation, we were able to show that psen1 performs similar roles to that of its mouse orthologue during embryogenesis.

The function of Psen2 in zebrafish embryos has been analysed by Campbell et al. [16] in the context of its participation in the γ-secretase complex with the protein product of the zebrafish orthologue of human PEN2, psenen. These authors noted that inhibition of Psen2 translation by the morpholino “Psen2MO1” reduced expression of the gene her6 that is thought to be a target of Notch signalling in the developing retina [17]. We have previously shown that inhibition of Psen2 translation increases the number of Dorsal Longitudinal Ascending (DoLA) interneurons that differentiate in the developing spinal cord of zebrafish embryos. Since these cells are unaffected by decreased translation of Psen1 we used this phenomenon to demonstrate that truncated forms of Psen1 protein appear to have the ability to inhibit the function of Psen2 in a dominant negative manner [15].

In this paper we compare the activities of Psen1 and Psen2 in the differentiation of two cell types in zebrafish embryos, melanocytes and DoLAs. Inhibition of Psen2 (or Psen1) translation causes loss of trunk and tail (but not cranial) melanocytes and a reciprocal increase in Rohon-Beard neuron number apparently due to diminished Notch signalling. Interestingly, differentiation of another spinal cord neuron type, Dorsal Longitudinal Ascending (DoLA) interneurons, is affected in an unequal fashion by loss of Psen2 or Psen1. Psen2 loss increases DoLA number, while Psen1 loss has no effect. However, the effect on DoLA number of Psen2 loss is ameliorated by loss of Psen1. The effects of Psen2 loss on DoLA and melanocyte cell numbers provide sensitive bioassays for analysis of the non-apoptotic activity of Psen2.

Section snippets

Ethics

This work was conducted under the auspices of The Animal Ethics Committee of The University of Adelaide and in accordance with EC Directive 86/609/EEC for animal experiments and the Uniform Requirements for manuscripts submitted to Biomedical journals.

Morpholinos and RNA injection

Morpholinos were synthesised by Gene Tools (LLC, Corvallis, OR, USA) and are listed in Table 1. They were dissolved in distilled water at a concentration of 2 mM. All morpholino injections were preformed at 1 mM total morpholino concentration.

Morpholinos inhibiting Psen2 protein translation

Two morpholino antisense oligonucleotides, “Psen2MO1” [16] and “MoPS2Tln” [15], have previously been used successfully to inhibit translation of Psen2 protein in zebrafish embryos but description of their phenotypic effects has been very limited. Psen2MO1 binds over the translation start codon of psen2 mRNA while MoPS2Tln binds in a non-overlapping region of the 5′ untranslated region (5′UTR). Injection of either of these morpholinos into fertilised eggs results in similar developmental defects

Psen2 has non-redundant roles in zebrafish embryogenesis

In this paper we have analysed the effects of changes in Psen1 and Psen2 activity on the development of three zebrafish cell types, melanocytes, Rohon-Beard dorsal sensory neurons and DoLA interneurons. This revealed that Psen2 has important and non-redundant roles in development of zebrafish embryos in contrast to the results published for mice [9] (and see below). Decreased Psen2 activity causes decreased melanocyte formation and increased neuron number, apparently through changes in Notch

Acknowledgments

This work was supported by a project grant from the National Health and Medical Research Council of Australia (453622), the Cancer Council of South Australia (S 24/04), the ARC Special Research Centre for the Molecular Genetics of Development (S00001541) and the School of Molecular and Biomedical Sciences of The University of Adelaide. Professor Martins is supported by grants from the McCusker Foundation for Alzheimer's Disease Research, Department of Veterans Affairs, National Health and

References (38)

  • C.H. Kim et al.

    Zebrafish elav/HuC homologue as a very early neuronal marker

    Neurosci. Lett.

    (1996)
  • R.N. Kelsh et al.

    Expression of zebrafish fkd6 in neural crest-derived glia

    Mech. Dev.

    (2000)
  • S. Roy et al.

    Blimp-1 specifies neural crest and sensory neuron progenitors in the zebrafish embryo

    Curr. Biol.

    (2004)
  • G. Struhl et al.

    Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo

    Cell

    (1993)
  • K. Dillen et al.

    A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: are we progressing toward therapy?

    Int. Rev. Cytol.

    (2006)
  • J.E. Meredith et al.

    Gamma-secretase activity is not involved in presenilin-mediated regulation of beta-catenin

    Biochem. Biophys. Res. Commun.

    (2002)
  • K. Echeverri et al.

    Coordination of symmetric cyclic gene expression during somitogenesis by Suppressor of Hairless involves regulation of retinoic acid catabolism

    Dev. Biol.

    (2007)
  • A.J. Beel et al.

    Substrate specificity of gamma-secretase and other intramembrane proteases

    Cell. Mol. Life Sci.

    (2008)
  • M.L. Hemming et al.

    Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements

    PLoS Biol.

    (2008)
  • Cited by (0)

    View full text